Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DHAI NASDAQ:ECOR NASDAQ:MODD NASDAQ:NEPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDHAIDIH Holding US$0.20+3.0%$0.25$0.12▼$2.93$9.37M0.0914.21 million shs1.21 million shsECORelectroCore$4.74-5.6%$6.04$4.16▼$19.49$38.07M0.3662,472 shs31,640 shsMODDModular Medical$0.75+7.1%$0.72$0.63▼$2.50$38.70M0.17359,909 shs14.45 million shsNEPHNephros$4.26+1.2%$3.82$1.36▼$5.00$44.63M1.2342,731 shs30,254 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDHAIDIH Holding US+2.98%-16.71%-15.50%-7.74%-91.32%ECORelectroCore-5.58%-3.07%-7.78%-6.88%-21.26%MODDModular Medical+7.11%+4.70%+3.09%-2.60%-64.29%NEPHNephros+1.19%+11.23%+3.40%+10.08%+125.99%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDHAIDIH Holding US$0.20+3.0%$0.25$0.12▼$2.93$9.37M0.0914.21 million shs1.21 million shsECORelectroCore$4.74-5.6%$6.04$4.16▼$19.49$38.07M0.3662,472 shs31,640 shsMODDModular Medical$0.75+7.1%$0.72$0.63▼$2.50$38.70M0.17359,909 shs14.45 million shsNEPHNephros$4.26+1.2%$3.82$1.36▼$5.00$44.63M1.2342,731 shs30,254 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDHAIDIH Holding US+2.98%-16.71%-15.50%-7.74%-91.32%ECORelectroCore-5.58%-3.07%-7.78%-6.88%-21.26%MODDModular Medical+7.11%+4.70%+3.09%-2.60%-64.29%NEPHNephros+1.19%+11.23%+3.40%+10.08%+125.99%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDHAIDIH Holding US 0.00N/AN/AN/AECORelectroCore 3.00Buy$25.50437.97% UpsideMODDModular Medical 0.00N/AN/AN/ANEPHNephros 3.00Buy$5.5029.11% UpsideCurrent Analyst Ratings BreakdownLatest DHAI, NEPH, MODD, and ECOR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/8/2025NEPHNephrosMaxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$4.50 ➝ $6.00(Data available from 9/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDHAIDIH Holding US$64.47M0.15N/AN/A($0.80) per share-0.25ECORelectroCore$27.70M1.30N/AN/A$1.13 per share4.19MODDModular MedicalN/AN/AN/AN/A$0.42 per shareN/ANEPHNephros$14.16M3.19$0.02 per share210.38$0.81 per share5.26Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDHAIDIH Holding US-$8.44M-$0.30N/A∞N/A-13.59%N/A-25.97%N/AECORelectroCore-$11.89M-$1.62N/AN/AN/A-47.84%-221.93%-69.17%11/12/2025 (Estimated)MODDModular Medical-$18.82M-$0.51N/A∞N/AN/A-185.60%-158.95%11/12/2025 (Estimated)NEPHNephros$70K$0.1235.50∞N/A7.95%14.89%11.64%11/6/2025 (Estimated)Latest DHAI, NEPH, MODD, and ECOR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q1 2026MODDModular Medical-$0.10-$0.12-$0.02-$0.12$0.20 millionN/A8/7/2025Q2 2025NEPHNephros-$0.0250$0.02+$0.0450$0.02$3.60 million$4.40 million8/6/2025Q2 2025ECORelectroCore-$0.32-$0.35-$0.03-$0.44$7.24 million$7.38 million6/20/2025Q4 2025MODDModular Medical-$0.11-$0.12-$0.01-$0.12N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDHAIDIH Holding USN/AN/AN/AN/AN/AECORelectroCoreN/AN/AN/AN/AN/AMODDModular MedicalN/AN/AN/AN/AN/ANEPHNephrosN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDHAIDIH Holding USN/A0.510.34ECORelectroCoreN/A1.100.95MODDModular MedicalN/A4.044.04NEPHNephrosN/A5.414.14Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDHAIDIH Holding US27.76%ECORelectroCore26.74%MODDModular Medical27.47%NEPHNephros41.10%Insider OwnershipCompanyInsider OwnershipDHAIDIH Holding US27.00%ECORelectroCore13.80%MODDModular Medical20.46%NEPHNephros6.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDHAIDIH Holding USN/A47.34 million34.56 millionN/AECORelectroCore507.58 million6.54 millionNot OptionableMODDModular Medical2055.28 million43.97 millionNot OptionableNEPHNephros3010.60 million9.89 millionNot OptionableDHAI, NEPH, MODD, and ECOR HeadlinesRecent News About These CompaniesNephros' (NASDAQ:NEPH) Returns On Capital Are Heading HigherSeptember 6, 2025 | finance.yahoo.comNephros Second Quarter 2025 Earnings: Beats ExpectationsAugust 10, 2025 | finance.yahoo.comNephros Inc (NEPH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Profitability ...August 9, 2025 | finance.yahoo.com�Nephros Announces Strong Second Quarter Financial ResultsAugust 7, 2025 | prismmediawire.comPNephros Announces Strong Second Quarter Financial ResultsAugust 7, 2025 | globenewswire.com�Nephros Schedules Second Quarter 2025 Financial Results Conference CallJuly 31, 2025 | prismmediawire.comPNephros Schedules Second Quarter 2025 Financial Results Conference CallJuly 31, 2025 | globenewswire.comNephros Inc. (NEPH) Stock Price Today - WSJJuly 4, 2025 | wsj.comJune 2025's Promising Penny Stocks With Growth PotentialJune 23, 2025 | finance.yahoo.comNephros, Inc. (NASDAQ:NEPH) Shares Could Be 37% Below Their Intrinsic Value EstimateJune 23, 2025 | uk.finance.yahoo.comNephros to Host Analyst and Investor Virtual EventMay 30, 2025 | finance.yahoo.comNephros First Quarter 2025 Earnings: Beats ExpectationsMay 10, 2025 | finance.yahoo.comNephros’s new microfilter offers enhanced installation flexibility for bacterial retentionApril 30, 2025 | filtsep.comFNephros Schedules First Quarter 2025 Financial Results Conference CallApril 30, 2025 | finance.yahoo.comNephros expands filtration line with new S100 In-Line filterApril 29, 2025 | investing.comNephros Launches New S100 In-Line MicrofilterApril 28, 2025 | finance.yahoo.comNephros Full Year 2024 Earnings: Beats ExpectationsMarch 28, 2025 | finance.yahoo.comEQS-News: Nephros Announces Fourth Quarter and Fiscal Year 2024 Financial ResultsMarch 8, 2025 | markets.businessinsider.comNephros Announces Fourth Quarter and Fiscal Year 2024 Financial ResultsMarch 7, 2025 | theglobeandmail.comNephros Amends CFO Employment Terms for Strategic GrowthMarch 4, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDHAI, NEPH, MODD, and ECOR Company DescriptionsDIH Holding US NASDAQ:DHAI$0.20 +0.01 (+2.98%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$0.20 -0.01 (-3.38%) As of 09/12/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.electroCore NASDAQ:ECOR$4.74 -0.28 (-5.58%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$4.89 +0.15 (+3.08%) As of 09/12/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.Modular Medical NASDAQ:MODD$0.75 +0.05 (+7.11%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$0.75 0.00 (-0.13%) As of 09/12/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.Nephros NASDAQ:NEPH$4.26 +0.05 (+1.19%) Closing price 09/12/2025 03:57 PM EasternExtended Trading$4.23 -0.03 (-0.70%) As of 09/12/2025 05:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Tesla's U.S. Market Is At An 8-Year Low... How Bad Could It Get? Not Just NVDA: 3 Semiconductor Stocks Struggling This Quarter Broadcom Gets Big Upgrades: How High Analysts See Shares Going Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
